Earth Science Tech Inc. (OTCQB: ETST) is driving sustainable growth by leveraging artificial intelligence and other technologies, supported by a focused in-house IT department, according to a recent press release. The company, a strategic holding company with businesses in healthcare, pharmacy, technology, telemedicine, real estate, and consumer products, is using technology to cut costs, improve operational efficiencies, and expand profit margins within its pharmacy and telemedicine platforms. During the recent Annual Meeting of Shareholders, Chief Technology Officer Chris Rose detailed the company's tech stack and developments that have enabled it to offer its in-house tools to other clinics as a white-label service.
Rose emphasized the company's strategy to build rather than buy, augmented by AI. "We build now instead of buy, supported by advancements in and our leverage of AI," he said. "We've built our own ETST-wide software and data platform that ties together the three pharmacies, our curative telehealth business, and My Online Consultation doctor's" services. This integrated platform allows for streamlined operations and data sharing across the company's diverse healthcare assets.
The implications of this announcement are significant for investors and the healthcare industry. By developing its own technology, ETST can reduce dependency on third-party vendors, potentially lowering costs and increasing control over its operations. The use of AI to drive down costs and improve efficiencies could lead to higher profit margins, making the company more attractive to investors. Furthermore, the ability to offer its tools as a white-label service to other clinics opens up a new revenue stream and positions ETST as a technology provider in the healthcare space, not just a service provider.
For the broader healthcare industry, ETST's approach highlights the growing trend of integrating AI and proprietary technology to enhance patient care and operational efficiency. As healthcare costs continue to rise, solutions that improve margins while maintaining quality of care are increasingly valuable. ETST's success could encourage other healthcare companies to invest in similar in-house technology development.
Investors can stay updated on ETST's latest news and developments through the company's newsroom at https://ibn.fm/ETST. The press release was distributed by BioMedWire, a specialized communications platform focused on the biotechnology, biomedical sciences, and life sciences sectors. BioMedWire is part of the Dynamic Brand Portfolio at IBN, which offers access to a vast network of wire solutions via InvestorWire, article and editorial syndication to 5,000+ outlets, enhanced press release enhancement, social media distribution, and tailored corporate communications solutions. For more information, visit https://www.BioMedWire.com. Full terms of use and disclaimers are available at https://www.BioMedWire.com/Disclaimer.
